Byoung Uk Park

Byoung Uk Park

Auto-generated profile, based on publicly available information

Byoung Uk Park

Department of Pathology University of Minnesota Minneapolis Minnesota USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2024 in The American Journal of Surgery
Verified
Journal Article
Closed access
GBGrace C. Bloomfield
Grace C. Bloomfield
PRPejman Radkani
Pejman Radkani
ANAradhya Nigam
Aradhya Nigam
JNJean Namgoong
Jean Namgoong
JCJiling Chou
Jiling Chou
EWEmily R. Winslow
Emily R. Winslow

17 November 2022 in Heliyon
Verified
Journal Article
Open access
NANathan Aminpour
Nathan Aminpour
OSOlutayo Sogunro
Olutayo Sogunro
PTParhom Towfighi
Parhom Towfighi
BPByoung Uk Park
Byoung Uk Park
MBMarc Boisvert
Marc Boisvert
Myoid Hamartoma of the breast (MHB) is an extremely rare benign breast lesion composed of mammary ducts and lobules, fibrous stroma, adipose tissue, and smooth muscle. Due to its rarity, the clinical management of MHB is not well described. Surgical excision is the most common form of management. This study reviews the current literature on the clinical management of MHB and describes a case report of a young patient presenting with MHB managed with surveillance and shared-decision making. A healthy 23-year-old female presented with a one-year history of a palpable left breast mass. Her right breast exam was normal. Ultrasound of the left breast revealed a 2.7 cm × 1.4 cm × 2.4 cm lobulated mass at the one o'clock position. The mass caused slight discomfort to palpation but otherwise had no associated skin changes. Ultrasound-guided biopsy revealed a left breast myoid hamartoma. Management options were presented to the patient, and she elected to observe the mass with surveillance imaging. There have been no reported cases in the literature of malignant transformation of MHB. Rather than rely on reflexive surgical excision of MHB, our review suggests that surveillance and routine imaging may be an appropriate form of clinical management in patients who present with a favorable clinical and histopathological profile which includes: a low MIB-1 proliferative index, low breast cancer risk assessment score, lesion size less than 1.2 cm, and radiological-pathological concordance. Further research is needed to determine the clinical significance and threshold levels of these clinical and histopathological factors in patient care. However, given current trends to minimize over treatment in breast pathology, we pose that observation of MHB can be performed when favorable clinical criteria is met.

22 December 2025 in Journal of Pathology Informatics
Verified
Journal Article
Open access
PSPriyadharshini Sivasubramaniam
Priyadharshini Sivasubramaniam
ASAbdelrahman Shabaan
Abdelrahman Shabaan
RERofyda Elhalaby
Rofyda Elhalaby
BHBashar Hasan
Bashar Hasan
APAmeya A. Patil
Ameya A. Patil
RMRoger K. Moreira
Roger K. Moreira
Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease that can progress to fibrostenotic complications. Lamina propria fibrosis (LPF) plays a critical role in this progression but is difficult to assess reliably in routine biopsies. We aimed to develop and validate an artificial intelligence (AI) model to quantify LPF on hematoxylin and eosin (H&E)-stained slides and to evaluate its ability to predict fibrostenotic disease. We used a cloud-based platform (Aiforia Inc., Cambridge, MA, USA) to train a supervised AI model to recognize several histological features of EoE, including LPF. Our validation cohort consisted of 213 esophageal biopsy whole-slide images, including 100 adult and 113 pediatric samples with mucosal eosinophilia, which were prospectively evaluated in our anatomic pathology service between 2020 and 2021 using a standardized histological scoring system. AI-based LPF scores were correlated with the development of fibrostenotic disease on subsequent endoscopies after a median follow-up time of 31.4 months. The AI fibrosis score correlated with pathologist-determined LPF (Spearman's Rs = 0.64–0.69, p < 0.0001) and outperformed pathologists' assessments in predicting fibrostenotic outcomes. Higher AI fibrosis scores were associated with the development of rings, strictures, and need for dilatation on follow-up (p < 0.01), including in cases deemed histologically inadequate by pathologists and in the subgroup without prior strictures. In a Cox Proportional-Hazards model, the AI fibrosis score was an independent predictor of strictures (C-index = 0.73, p = 0.004). Importantly, meaningful predictions were achievable with smaller amounts of lamina propria than traditionally deemed sufficient. This study demonstrates that AI-based quantification of LPF on routine H&E slides provides an objective and clinically meaningful assessment of fibrosis in EoE. The AI fibrosis score predicts fibrostenotic disease more consistently than conventional pathology evaluation and may improve risk stratification even in limited biopsy samples. Integration of digital pathology tools may enhance histological assessment of fibrosis in EoE and support clinical decision-making.

1 October 2025
Verified
Book Chapter
Closed access
PDF file
BPByoung Uk Park
Byoung Uk Park
ZCZongming Eric Chen
Zongming Eric Chen

11 April 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
MPMatt Paz
Matt Paz
AHAmira Hamed
Amira Hamed
BABashar Aldaraiseh
Bashar Aldaraiseh
MAMohammad Alutaibi
Mohammad Alutaibi
MKM.ZAki Karzoun
M.ZAki Karzoun
BPByoung Uk Park
Byoung Uk Park
Claudin-18 isoform 2 (CLDN18.2) is a tight junction protein that may become exposed on the tumor cell surface with loss of epithelial polarity, enabling therapeutic targeting. Although CLDN18.2-directed therapies have demonstrated efficacy in gastric and gastroesophageal adenocarcinoma, its expression in lower rectal adenocarcinomas remains poorly defined.Following institutional review board approval (STUDY00025960), we retrospectively evaluated primary rectal adenocarcinomas arising within 2 cm of the dentate line. CLDN18.2 immunohistochemistry was performed, with positivity defined as any tumor cell staining. Clinicopathologic features and outcomes were compared.Among 37 cases, 6 (16.2%) were CLDN18.2-positive. Most clinicopathologic variables were similar between groups. However, CLDN18.2-positive tumors were located significantly closer to the dentate line than CLDN18.2-negative tumors (mean 0.12 cm vs 0.59 cm; p=0.01). CLDN18.2-positive cases also showed higher observed recurrence (83.3% vs 29.0%; p=0.02) and shorter recurrence-free survival on univariate analysis, without a significant difference in overall survival.CLDN18.2 expression is present in a subset of lower rectal adenocarcinomas, particularly in tumors arising near the anorectal junction. These findings suggest possible anatomic and biologic heterogeneity in this setting. While an association with recurrence was observed, this should be interpreted cautiously given the small cohort size. Nevertheless, the identification of CLDN18.2 expression in this subset raises the possibility of biologic relevance with potential implications for future therapeutic stratification.

27 May 2026 in Human Pathology
Verified
Journal Article
Closed access
AJAhmed Jamshed
Ahmed Jamshed
FZFang Zhu
Fang Zhu
DCDavid Cartwright
David Cartwright
KTKevin Turner
Kevin Turner
KAKhalid Amin
Khalid Amin
BPByoung Uk Park
Byoung Uk Park